Aligos Therapeutics, Inc. (ALGS)
 NASDAQ: ALGS · Real-Time Price · USD
 8.23
 +0.03 (0.37%)
  Oct 31, 2025, 1:38 PM EDT - Market open
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $50.63 million as of October 31, 2025. Its market cap has increased by 117.88% in one year.
Market Cap 
 50.63M
Enterprise Value 
 -66.24M
1-Year Change 
 117.88%
Ranking 
 Category 
 Stock Price 
$8.23
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $50.63M, a decrease of -90.85%. That is a compound annual growth rate of -37.77%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 50.44M | -65.89% | 
| Dec 31, 2024 | 147.87M | 197.20% | 
| Dec 29, 2023 | 49.75M | 21.95% | 
| Dec 30, 2022 | 40.80M | -91.93% | 
| Dec 31, 2021 | 505.85M | -52.00% | 
| Dec 31, 2020 | 1.05B | 90.47% | 
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 730.33B | 
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B |